FWM
BIIB icon

Frontier Wealth Management’s Biogen BIIB Stock Holding History

Frontier Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-977
Closed -$338K – 424
2021
Q2 		$338K Buy
977
+43
+5% +$13K 0.02% 316
2021
Q1 		$261K Hold
934
– – 0.02% 321
2020
Q4 		$229K Sell
934
-73
-7% -$18.8K 0.02% 335
2020
Q3 		$286K Hold
1,007
– – 0.03% 287
2020
Q2 		$269K Sell
1,007
-139
-12% -$41.8K 0.02% 288
2020
Q1 		$363K Buy
1,146
+50
+5% +$15.2K 0.06% 202
2019
Q4 		$325K Hold
1,096
– – 0.05% 221
2019
Q3 		$255K Hold
1,096
– – 0.04% 262
2019
Q2 		$256K Sell
1,096
-2,600
-70% -$600K 0.04% 259
2019
Q1 		$874K Sell
3,696
-511
-12% -$161K 0.12% 156
2018
Q4 		$1.27M Hold
4,207
– – 0.19% 119
2018
Q3 		$1.49M Buy
4,207
+43
+1% +$14.8K 0.14% 118
2018
Q2 		$1.21M Sell
4,164
-21
-0.5% -$5.9K 0.17% 128
2018
Q1 		$1.15M Buy
4,185
+414
+11% +$129K 0.16% 139
2017
Q4 		$1.2M Sell
3,771
-1,100
-23% -$353K 0.19% 121
2017
Q3 		$1.52M Sell
4,871
-270
-5% -$80K 0.22% 110
2017
Q2 		$1.4M Sell
5,141
-131
-2% -$34.6K 0.21% 116
2017
Q1 		$1.44M Sell
5,272
-206
-4% -$58.2K 0.22% 115
2016
Q4 		$1.55M Buy
5,478
+4,517
+470% +$1.34M 0.25% 108
2016
Q3 		$301K Buy
+961
New +$285K 0.05% 277
2016
Q2 		– Sell
-982
Closed -$256K – 342
2016
Q1 		$256K Buy
982
+184
+23% +$48.6K 0.02% 278
2015
Q4 		$244K Buy
798
+3
+0.4% +$862 0.04% 283
2015
Q3 		$232K Buy
795
+20
+3% +$6.61K 0.04% 285
2015
Q2 		$313K Buy
+775
New +$311K 0.05% 249

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Frontier Wealth Management's BIIB Position: Q3 2021 in Review

Frontier Wealth Management sold out of Biogen (BIIB) in Q3 2021, closing a stake of 977 shares — an estimated $338K sold.

Frontier Wealth Management first reported a position in BIIB in Q2 2015 and held it in 24 quarters. The position peaked at $1.55M in Q4 2016. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q3 2021.

  • Frontier Wealth Management reported no remaining Biogen position as of Q3 2021 after selling out during the quarter.
  • Frontier Wealth Management sold 977 Biogen shares in Q3 2021, an estimated $338K.
  • Frontier Wealth Management first reported a position in Biogen in Q2 2015 and held it in 24 quarters.
  • Frontier Wealth Management's Biogen position peaked at $1.55M in Q4 2016.
  • 1,041 funds tracked by Wall St. Rank held Biogen as of Q3 2021.

Based on Frontier Wealth Management's 13F filing for Q3 2021, filed 12 Nov 2021.